Spontaneous PD has been linked to polymorphisms in the HLA-DR region. By potentially working against tau, an adaptive immune response mediated by HLA-DRB1 lowers the risk of PD and AD and opens up prospective treatment options. This evidence concerns the gene MAPT and Alzheimer disease.